首页|氯沙坦钾原料药降解途径与降解杂质分析

氯沙坦钾原料药降解途径与降解杂质分析

扫码查看
目的 通过强制降解试验探讨氯沙坦钾原料药的降解杂质和降解途径。方法 建立氯沙坦钾及其有关物质的高效液相(HPLC)分析方法,采用Waters XBridge BEH C18(4。6 mm×250 mm,5 μm)色谱柱,流动相为0。05%磷酸水溶液-乙腈,梯度洗脱,流速为1。0 mL·min-1,柱温设置为30℃,检测波长210 nm,对氯沙坦钾降解溶液中主峰含量进行测定,探讨氯沙坦钾原料药在氧化、酸、碱、高温、光照条件下的降解率。结果 在本实验设计的67种降解条件中,氯沙坦钾原料药对氧化(加热和室温)、高温高湿、酸环境敏感,同时在溶液状态下对高温和光照条件敏感。并确定氯沙坦钾强制降解后的4个降解杂质的分子结构及其质谱裂解反应机理。结论 本试验以强制降解中所涉及的多种环境模拟对氯沙坦钾降解过程的研究,有助于探索药品贮藏及药品制剂生产中的杂质变化。
Analysis of degradation pathways and impurities of losartan potassium
Objective To explore the degradation pathway of losartan potassium active pharmaceutical ingredient(API)through forced degradation test.Methods A high performance liquid chromatographic(HPLC)method was devel-oped for the determination of losartan potassium and its related substances on a Waters XBridge BEH C18(4.6 mm × 250 mm,5 μm)column with a mobile phase of 0.05%aqueous phosphoric acid solution-acetonitrile,gradient elution,flow rate of 1.0 mL·min-1,column temperature set at 30 ℃,detection wavelength 210 nm.The content of the main peak in the degra-dation solution of losartan potassium was determined to explore the degradation rate of losartan potassium API under the conditions of oxidation,acid hydrolysis,alkaline hydrolysis,thermal and photolysis.Results Among the 67 degradation con-ditions designed for this experiment,losartan potassium API was sensitive to oxidation(heating and room temperature),high temperature accompanied with high humidity,acidic condition environment,while in solution state it was sensitive to high temperature and light conditions.The molecular structures of four degradation impurities of losartan potassium were deter-mined,and their mass spectrum cleavage reaction mechanisms were clarified.Conclusion This experiment was conducted to simulate the degradation process of losartan potassium with a variety of environments involved in forced degradation.The study helps to explore the changes in impurities in drug storage and drug formulation production for quality control of losar-tan potassium API and its formulations.

Losartan potassiumOxidative destroyingAcid destroyingAlkali destroyingHigh temperature destroyingLight destroyingDegradation impurities

潘静、夏佳璇、金一宝、汤佳、王冰、黄晓龙

展开 >

国家药品监督管理局药品审评检查大湾区分中心,广东深圳 518017

深圳市药品检验研究院,国家药品监督管理局仿制药评价生物等效性研究重点实验室,深圳市药品质量标准研究重点实验室,广东深圳 518057

中山大学药学院<深圳>,广东深圳 518107

氯沙坦钾 氧化破坏 酸破坏 碱破坏 高温破坏 光照破坏 降解杂质

国家"重大新药创制"科技重大专项资助项目

2017zx09101001/03/04

2024

药学研究
山东省药品检验所 山东省药学会

药学研究

CSTPCD
影响因子:0.653
ISSN:2095-5375
年,卷(期):2024.43(2)
  • 19